ノイルイミューン・バイオテック株式会社 · Pharmaceutical · FY ends Dec
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Takeda Pharmaceutical Co., Ltd. | 8,119,800 | 18.75% | — | — |
| 2 | 株式会社鶴亀 | 7,159,550 | 16.53% | — | — |
| 3 | 玉田 耕治 | 3,750,000 | 8.66% | — | — |
| 4 | KOREA SECURITIES DEPOSITORY-SAMSUNG | 3,678,720 | 8.49% | — | — |
| 5 | 瀬戸 恭子 | 1,700,000 | 3.92% | — | — |
| 6 | 大和日台バイオベンチャー投資事業有限責任組合 | 1,349,200 | 3.11% | — | — |
| 7 | 荻原 弘子 | 1,000,000 | 2.30% | — | — |
| 8 | 佐古田 幸美 | 1,000,000 | 2.30% | — | — |
| 9 | 和田 聡 | 956,900 | 2.20% | — | — |
| 10 | 石崎 秀信 | 760,000 | 1.75% | — | — |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| 玉田 耕治 | President & Representative Director | 3,750,000 | — | — |
| 渡嘉敷 努 | Director | 25,000 | — | — |
| 永井 寛子 | Director | — | — | — |
| フィリップ・フォシェ | Director | — | — | — |
| 花井 陳雄 | Director | — | — | — |
| 藤原 一幸 | Full-time Audit & Supervisory Board Member | — | — | — |
| 橋岡 宏成 | Audit & Supervisory Board Member | 350,000 | — | — |
| 中田 幸康 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Dec 2025 | — | ¥-18.33 | — | — | 43,301,765 |
| FY ending Dec 2024 | — | ¥-22.28 | — | — | 43,301,765 |